Explore
Trendline
Brainstorm Cell Therapeutics Reports Narrowed Loss in Q1 2026 Amid Clinical Developments
Brainstorm Cell Therapeutics Reports Narrowed Loss in Q1 2026 Amid Clinical Developments
Read More
Trendline
Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase
Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase
Read More
Trendline
NanoViricides Reports $1.99M Net Loss in Q3 FY2026 Amid Clinical Advancements
NanoViricides Reports $1.99M Net Loss in Q3 FY2026 Amid Clinical Advancements
Read More
Trendline
Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress
Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress
Read More
Trendline
Brainstorm Cell Therapeutics Reports Narrowed Losses in Q1 2026
Brainstorm Cell Therapeutics Reports Narrowed Losses in Q1 2026
Read More
Trendline
BrainStorm Cell Therapeutics Announces Financial Results and Updates on ALS Treatment Development
BrainStorm Cell Therapeutics Announces Financial Results and Updates on ALS Treatment Development
Read More
Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Read More
Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Strategic Developments
Spruce Biosciences Reports Q1 2026 Financial Results and Strategic Developments
Read More
Trendline
Savara Reports Increased Losses in Q1 2026 Amid Regulatory Milestones for MOLBREEVI
Savara Reports Increased Losses in Q1 2026 Amid Regulatory Milestones for MOLBREEVI
Read More
Trendline
Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements
Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements
Read More
Trendline
Spruce Biosciences Strengthens Financial Position Ahead of Potential U.S. Launch of TA-ERT
Spruce Biosciences Strengthens Financial Position Ahead of Potential U.S. Launch of TA-ERT
Read More
Trendline
Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue
Guided Therapeutics Reports Q1 2026 Financial Results with No Revenue
Read More
